Detalhe da pesquisa
1.
Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma.
Drug Resist Updat
; 73: 101052, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262246
2.
Change of indocyanine green clearance ability and liver function after transcatheter intra-arterial therapies and its impact on outcomes of resectable hepatocellular carcinoma: a retrospective cohort study.
Int J Surg
; 110(5): 2832-2844, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363991
3.
Comparison of stereotactic body radiation therapy with hepatic resection and radiofrequency ablation as initial treatment in patients with early-stage hepatocellular carcinoma.
Front Oncol
; 12: 948866, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479067
4.
PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma.
Cancer Res
; 82(18): 3307-3320, 2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802648
5.
Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma.
Front Oncol
; 11: 618206, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718175